Logo image of IMAX

IMAX CORP (IMAX) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:IMAX - CA45245E1097 - Common Stock

35.71 USD
-0.52 (-1.44%)
Last: 12/5/2025, 8:04:00 PM
35.71 USD
0 (0%)
After Hours: 12/5/2025, 8:04:00 PM
Fundamental Rating

6

Taking everything into account, IMAX scores 6 out of 10 in our fundamental rating. IMAX was compared to 80 industry peers in the Entertainment industry. While IMAX has a great health rating, its profitability is only average at the moment. IMAX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

In the past year IMAX was profitable.
IMAX had a positive operating cash flow in the past year.
In multiple years IMAX reported negative net income over the last 5 years.
Of the past 5 years IMAX 4 years had a positive operating cash flow.
IMAX Yearly Net Income VS EBIT VS OCF VS FCFIMAX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

1.2 Ratios

IMAX has a Return On Assets of 4.45%. This is in the better half of the industry: IMAX outperforms 80.00% of its industry peers.
The Return On Equity of IMAX (11.31%) is better than 80.00% of its industry peers.
The Return On Invested Capital of IMAX (7.73%) is better than 81.25% of its industry peers.
The Average Return On Invested Capital over the past 3 years for IMAX is below the industry average of 9.08%.
The last Return On Invested Capital (7.73%) for IMAX is above the 3 year average (4.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROIC 7.73%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
IMAX Yearly ROA, ROE, ROICIMAX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10 -20 -30

1.3 Margins

The Profit Margin of IMAX (10.47%) is better than 83.75% of its industry peers.
IMAX's Profit Margin has declined in the last couple of years.
With an excellent Operating Margin value of 19.91%, IMAX belongs to the best of the industry, outperforming 91.25% of the companies in the same industry.
IMAX's Operating Margin has declined in the last couple of years.
IMAX's Gross Margin of 58.89% is fine compared to the rest of the industry. IMAX outperforms 67.50% of its industry peers.
In the last couple of years the Gross Margin of IMAX has remained more or less at the same level.
Industry RankSector Rank
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
IMAX Yearly Profit, Operating, Gross MarginsIMAX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50 -100

7

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IMAX is creating some value.
The number of shares outstanding for IMAX has been reduced compared to 1 year ago.
IMAX has less shares outstanding than it did 5 years ago.
The debt/assets ratio for IMAX is higher compared to a year ago.
IMAX Yearly Shares OutstandingIMAX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
IMAX Yearly Total Debt VS Total AssetsIMAX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

IMAX has an Altman-Z score of 2.70. This is not the best score and indicates that IMAX is in the grey zone with still only limited risk for bankruptcy at the moment.
IMAX's Altman-Z score of 2.70 is fine compared to the rest of the industry. IMAX outperforms 72.50% of its industry peers.
The Debt to FCF ratio of IMAX is 2.85, which is a good value as it means it would take IMAX, 2.85 years of fcf income to pay off all of its debts.
IMAX has a Debt to FCF ratio of 2.85. This is in the better half of the industry: IMAX outperforms 78.75% of its industry peers.
IMAX has a Debt/Equity ratio of 0.74. This is a neutral value indicating IMAX is somewhat dependend on debt financing.
IMAX has a Debt to Equity ratio of 0.74. This is in the lower half of the industry: IMAX underperforms 61.25% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Altman-Z 2.7
ROIC/WACC1.09
WACC7.09%
IMAX Yearly LT Debt VS Equity VS FCFIMAX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

IMAX has a Current Ratio of 2.47. This indicates that IMAX is financially healthy and has no problem in meeting its short term obligations.
IMAX has a better Current ratio (2.47) than 81.25% of its industry peers.
A Quick Ratio of 2.12 indicates that IMAX has no problem at all paying its short term obligations.
Looking at the Quick ratio, with a value of 2.12, IMAX is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.47
Quick Ratio 2.12
IMAX Yearly Current Assets VS Current LiabilitesIMAX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

5

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 32.94% over the past year.
Measured over the past years, IMAX shows a decrease in Earnings Per Share. The EPS has been decreasing by -2.17% on average per year.
Looking at the last year, IMAX shows a quite strong growth in Revenue. The Revenue has grown by 9.30% in the last year.
IMAX shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -2.30% yearly.
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%

3.2 Future

IMAX is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 20.13% yearly.
Based on estimates for the next years, IMAX will show a small growth in Revenue. The Revenue will grow by 6.43% on average per year.
EPS Next Y43.78%
EPS Next 2Y28.33%
EPS Next 3Y19.57%
EPS Next 5Y20.13%
Revenue Next Year11.84%
Revenue Next 2Y9%
Revenue Next 3Y7.52%
Revenue Next 5Y6.43%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
IMAX Yearly Revenue VS EstimatesIMAX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 100M 200M 300M 400M
IMAX Yearly EPS VS EstimatesIMAX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 1 -1 2

6

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 31.60, which means the current valuation is very expensive for IMAX.
Compared to the rest of the industry, the Price/Earnings ratio of IMAX indicates a somewhat cheap valuation: IMAX is cheaper than 77.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.49, IMAX is valued at the same level.
A Price/Forward Earnings ratio of 22.82 indicates a rather expensive valuation of IMAX.
Based on the Price/Forward Earnings ratio, IMAX is valued a bit cheaper than 77.50% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of IMAX to the average of the S&P500 Index (23.69), we can say IMAX is valued inline with the index average.
Industry RankSector Rank
PE 31.6
Fwd PE 22.82
IMAX Price Earnings VS Forward Price EarningsIMAX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of IMAX indicates a somewhat cheap valuation: IMAX is cheaper than 66.25% of the companies listed in the same industry.
IMAX's Price/Free Cash Flow ratio is rather cheap when compared to the industry. IMAX is cheaper than 82.50% of the companies in the same industry.
Industry RankSector Rank
P/FCF 21.29
EV/EBITDA 15
IMAX Per share dataIMAX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

IMAX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
IMAX has a very decent profitability rating, which may justify a higher PE ratio.
IMAX's earnings are expected to grow with 19.57% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.72
PEG (5Y)N/A
EPS Next 2Y28.33%
EPS Next 3Y19.57%

0

5. Dividend

5.1 Amount

IMAX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

IMAX CORP

NYSE:IMAX (12/5/2025, 8:04:00 PM)

After market: 35.71 0 (0%)

35.71

-0.52 (-1.44%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)10-23 2025-10-23/bmo
Earnings (Next)02-17 2026-02-17
Inst Owners92.94%
Inst Owner Change2.61%
Ins Owners19.26%
Ins Owner Change-0.33%
Market Cap1.92B
Revenue(TTM)377.68M
Net Income(TTM)39.55M
Analysts81.11
Price Target39.78 (11.4%)
Short Float %14.98%
Short Ratio5.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.48%
Min EPS beat(2)20.24%
Max EPS beat(2)20.72%
EPS beat(4)3
Avg EPS beat(4)11.61%
Min EPS beat(4)-6.42%
Max EPS beat(4)20.72%
EPS beat(8)7
Avg EPS beat(8)65.63%
EPS beat(12)10
Avg EPS beat(12)54.13%
EPS beat(16)11
Avg EPS beat(16)15.31%
Revenue beat(2)0
Avg Revenue beat(2)-1.01%
Min Revenue beat(2)-1.46%
Max Revenue beat(2)-0.56%
Revenue beat(4)1
Avg Revenue beat(4)-3.09%
Min Revenue beat(4)-11.37%
Max Revenue beat(4)1.04%
Revenue beat(8)2
Avg Revenue beat(8)-0.56%
Revenue beat(12)6
Avg Revenue beat(12)1.35%
Revenue beat(16)7
Avg Revenue beat(16)2.11%
PT rev (1m)3.54%
PT rev (3m)16.26%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-9.48%
EPS NY rev (1m)0%
EPS NY rev (3m)8.13%
Revenue NQ rev (1m)-0.02%
Revenue NQ rev (3m)-4.63%
Revenue NY rev (1m)0.27%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 31.6
Fwd PE 22.82
P/S 5.09
P/FCF 21.29
P/OCF 17.6
P/B 5.5
P/tB 7.65
EV/EBITDA 15
EPS(TTM)1.13
EY3.16%
EPS(NY)1.56
Fwd EY4.38%
FCF(TTM)1.68
FCFY4.7%
OCF(TTM)2.03
OCFY5.68%
SpS7.02
BVpS6.5
TBVpS4.67
PEG (NY)0.72
PEG (5Y)N/A
Graham Number12.85
Profitability
Industry RankSector Rank
ROA 4.45%
ROE 11.31%
ROCE 9.75%
ROIC 7.73%
ROICexc 9.49%
ROICexgc 14.13%
OM 19.91%
PM (TTM) 10.47%
GM 58.89%
FCFM 23.9%
ROA(3y)1.16%
ROA(5y)-2.69%
ROE(3y)3.11%
ROE(5y)-6.85%
ROIC(3y)4.23%
ROIC(5y)N/A
ROICexc(3y)4.84%
ROICexc(5y)N/A
ROICexgc(3y)7.01%
ROICexgc(5y)N/A
ROCE(3y)5.33%
ROCE(5y)N/A
ROICexgc growth 3Y113.18%
ROICexgc growth 5Y-5.75%
ROICexc growth 3Y103.14%
ROICexc growth 5Y-8.28%
OM growth 3Y86.93%
OM growth 5Y-7.23%
PM growth 3YN/A
PM growth 5Y-8.99%
GM growth 3Y0.8%
GM growth 5Y-0.05%
F-Score8
Asset Turnover0.42
Health
Industry RankSector Rank
Debt/Equity 0.74
Debt/FCF 2.85
Debt/EBITDA 1.9
Cap/Depr 31.29%
Cap/Sales 5.01%
Interest Coverage 250
Cash Conversion 80.47%
Profit Quality 228.24%
Current Ratio 2.47
Quick Ratio 2.12
Altman-Z 2.7
F-Score8
WACC7.09%
ROIC/WACC1.09
Cap/Depr(3y)25.16%
Cap/Depr(5y)18.94%
Cap/Sales(3y)4.33%
Cap/Sales(5y)3.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.94%
EPS 3YN/A
EPS 5Y-2.17%
EPS Q2Q%34.29%
EPS Next Y43.78%
EPS Next 2Y28.33%
EPS Next 3Y19.57%
EPS Next 5Y20.13%
Revenue 1Y (TTM)9.3%
Revenue growth 3Y11.38%
Revenue growth 5Y-2.3%
Sales Q2Q%16.62%
Revenue Next Year11.84%
Revenue Next 2Y9%
Revenue Next 3Y7.52%
Revenue Next 5Y6.43%
EBIT growth 1Y94.17%
EBIT growth 3Y108.21%
EBIT growth 5Y-9.36%
EBIT Next Year245.67%
EBIT Next 3Y57.57%
EBIT Next 5Y34.08%
FCF growth 1Y52.72%
FCF growth 3YN/A
FCF growth 5Y-7.57%
OCF growth 1Y52.91%
OCF growth 3Y126.45%
OCF growth 5Y-4.76%

IMAX CORP / IMAX FAQ

What is the fundamental rating for IMAX stock?

ChartMill assigns a fundamental rating of 6 / 10 to IMAX.


What is the valuation status for IMAX stock?

ChartMill assigns a valuation rating of 6 / 10 to IMAX CORP (IMAX). This can be considered as Fairly Valued.


What is the profitability of IMAX stock?

IMAX CORP (IMAX) has a profitability rating of 6 / 10.


What is the valuation of IMAX CORP based on its PE and PB ratios?

The Price/Earnings (PE) ratio for IMAX CORP (IMAX) is 31.6 and the Price/Book (PB) ratio is 5.5.


What is the expected EPS growth for IMAX CORP (IMAX) stock?

The Earnings per Share (EPS) of IMAX CORP (IMAX) is expected to grow by 43.78% in the next year.